Pharmaceuticals

Impact BioMedical

Impact BioMedical released FY2025 Q4 earnings on March 11 (EST), actual revenue USD 7K, actual EPS USD 0.0572

Impact BioMedical released FY2025 Annual Earnings on March 11 (EST), actual revenue USD 32K, actual EPS USD -0.38

Impact BioMedical released FY2025 9 Months earnings on November 7 (EST), actual revenue USD 25K, actual EPS USD -1.4106

Impact BioMedical released FY2025 Q3 earnings on November 7, 2025 (EST), with actual revenue of USD 18K and EPS of USD -0.1206

Impact BioMedical released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 7K, actual EPS USD -1.1799

Impact BioMedical released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 7 K, actual EPS USD -1.29

DSS, Inc. Disposes of Impact Biomedical Inc. Common Stock

Impact BioMedical released FY2025 Q1 earnings on May 14 (EST) with actual revenue of USD 0 and EPS of USD -0.11

Impact BioMedical released FY2024 annual earnings on March 28, 2025 (EST) with actual revenue of 0 USD and EPS of -2.2999 USD

Impact BioMedical released FY2024 Q4 earnings on March 28 (EST) with actual revenue of 0 USD and EPS of -2.3552 USD

Impact BioMedical released FY2024 Q3 earnings on November 12 (EST) with actual revenue of 0 USD and EPS of 0.06 USD

Impact BioMedical released FY2024 9 Months Earnings on November 12 (EST), with actual revenue of 0 and EPS of -0.1299

Impact BioMedical released FY2024 Semi-Annual earnings on August 13 (EST) with actual revenue of USD 0 and EPS of USD -0.19

Robin Energy - WI

Fundrise Innovation Fund LLC

ENvue Medical

BlackRock Utilities, Infrastructure & Power Opportunities Trust

Quantum Biopharma

AleAnna

T-REX 2X Inverse CRCL Daily Target ETF

MKD Tech

CVD Equipment

Eagle Nuclear Energy

Eli Lilly

ROCHE HOLDINGS AG

Roche

AstraZeneca

NOVARTIS AG

Novo Nordisk AS

Chugai Pharmaceutical

UCB S.A.

Otsuka Pharmaceutical

Daiichi Sankyo

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Impact BioMedical(IBO.US)

Impact BioMedical Stock Performance Chart